INDIGO Home University of Illinois at Urbana-Champaign logo uic building uic pavilion uic student center

Rosiglitazone Improves Survival and Hastens Recovery from Pancreatic Inflammation in Obese Mice

Show full item record

Bookmark or cite this item:

Files in this item

File Description Format
PDF journal.pone.0040944.pdf (3MB) Main Article PDF
Title: Rosiglitazone Improves Survival and Hastens Recovery from Pancreatic Inflammation in Obese Mice
Author(s): Pini, Maria; Rhodes, Davina H.; Castellanos, Karla J.; Cabay, Robert J.; Grady, Eileen F.; Fantuzzi, Giamila
Abstract: Obesity increases severity of acute pancreatitis (AP) by unclear mechanisms. We investigated the effect of the PPAR-gamma agonist rosiglitazone (RGZ, 0.01% in the diet) on severity of AP induced by administration of IL-12+ IL-18 in male C57BL6 mice fed a low fat (LFD) or high fat diet (HFD), under the hypothesis that RGZ would reduce disease severity in HFD-fed obese animals. In both LFD and HFD mice without AP, RGZ significantly increased body weight and % fat mass, with significant upregulation of adiponectin and suppression of erythropoiesis. In HFD mice with AP, RGZ significantly increased survival and hastened recovery from pancreatic inflammation, as evaluated by significantly improved pancreatic histology, reduced saponification of visceral adipose tissue and less severe suppression of erythropoiesis at Day 7 post-AP. This was associated with significantly lower circulating and pancreas-associated levels of IL-6, Galectin-3, osteopontin and TIMP-1 in HFD + RGZ mice, particularly at Day 7 post-AP. In LFD mice with AP, RGZ significantly worsened the degree of intrapancreatic acinar and fat necrosis as well as visceral fat saponification, without affecting other parameters of disease severity or inflammation. Induction of AP lead to major suppression of adiponectin levels at Day 7 in both HFD and HFD + RGZ mice. In conclusion, RGZ prevents development of severe AP in obese mice even though it significantly increases adiposity, indicating that obesity can be dissociated from AP severity by improving the metabolic and inflammatory milieu. However, RGZ worsens selective parameters of AP severity in LFD mice.
Issue Date: 2012-07
Publisher: Public Library of Science
Citation Info: Pini, M., D. H. Rhodes, et al. (2012). "Rosiglitazone improves survival and hastens recovery from pancreatic inflammation in obese mice." PLoS One 7(7): e40944. DOI: 10.1371/journal.pone.0040944
Type: Article
Description: © 2012 Pini et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. The original version is available through Public Library of Science at DOI: 10.1371/journal.pone.0040944.
ISSN: 1932-6203
Sponsor: This study was supported by National Institues of Health grants DK083328 to GF and DK080787-03S3 to EFG.
Date Available in INDIGO: 2013-11-08

This item appears in the following Collection(s)

Show full item record


Country Code Views
United States of America 250
China 124
Russian Federation 30
United Kingdom 17
Germany 11


My Account


Access Key